D KEITH GROSSMAN

CIK 1218702 · Executive Chairman · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.64M

Companies

9

Total Filings

116

Lifetime Open-Market Net

-$10.59M

Filer Profile

Reported Address
3052 ORCHARD DRIVE
SAN JOSE, CA 95134
Related Filers
Zeltiq Aesthetics Inc — 8 joint filings, latest 2017-04-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OM Director 37,430 $3.21 $120.2K -$1.10M 19 2026-06-05
MMED Director 13,889 $22.50 $312.5K $0 1 2026-03-11
NEVRO CORP (NVRO) Delisted Director 0 $5.84 $0 $939.0K 43 2025-04-03
ViewRay, Inc. (VRAY) Delisted Director 100,855 $0.03 $2.5K $0 6 2021-01-05
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 0 $0 6 2017-04-28
THOR President & Chief Exec Officer 602,050 $26.17 $15.76M -$2.32M 20 2015-10-08
CONCEPTUS INC (CPTS) Delisted President & CEO 204,882 $0 3 2013-02-11
ISRG Director 36,450 $369.15 $13.46M -$8.12M 13 2010-04-23
KYPHON INC (KYPH) Delisted Director 64 $0 2 2007-05-09

Recent Filings · Page 3 of 12

116 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-09-06 NEVRO CORP (NVRO) Delisted Tax (F) −2,193 -$44.7K EDGAR
2023-07-26 NEVRO CORP (NVRO) Delisted Tax (F) −6,013 -$145.3K EDGAR
2023-06-06 NEVRO CORP (NVRO) Delisted Tax (F) −2,193 -$62.0K EDGAR
2023-05-31 OM Grant (A) +7,681 $0 EDGAR
2023-04-26 NEVRO CORP (NVRO) Delisted Grant (A) +22,841 $0 EDGAR
2023-04-13 NEVRO CORP (NVRO) Delisted Tax (F) −4,263 -$152.0K EDGAR
2023-03-14 NEVRO CORP (NVRO) Delisted Tax (F) −2,757 -$83.2K EDGAR
2023-03-07 NEVRO CORP (NVRO) Delisted Tax (F) −8,798 -$302.9K EDGAR
2022-06-01 OM Grant (A) +6,880 $0 EDGAR
2022-04-12 NEVRO CORP (NVRO) Delisted Tax (F) −4,263 $0 EDGAR
Showing 2130 of 116
Page 3 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.